7:30AM Geron: Geron increases stake in TA Therapeutics Joint Venture (GERN) 7.94 : Co announced that it and the Biotechnology Research Corporation of Hong Kong today announced that Geron has increased its stake in their joint venture entity, TA Therapeutics Limited, from 50% ownership to 75% ownership.
==========================================
7:31AM StemCells announces that Phase I clinical trial of HuCNS-SC has successfully completed enrollment (STEM) 2.46 : Co announces that the Phase I clinical trial of its proprietary HuCNS-SC product candidate has successfully completed enrollment of the low-dose cohort and will proceed to the high-dose cohort. This trial is designed to evaluate the safety and preliminary efficacy of the HuCNS-SC product candidate as a treatment for infantile and late infantile neuronal ceroid lipofuscinosis.